MyFinsight
Home
Blog
About
Contact
Download
Download image
Available-for-sale investments
$67,944K
Cash and cash
equivalents
$10,743K
Other receivables
$873K
Prepaid expenses
$677K
Property and equipment,
gross
$9,091K
Total current assets
$80,237K
Operating lease,
right-of-use assets
$5,524K
Property and equipment,
net
$4,263K
Restricted cash
$2,235K
Financing lease,
right-of-use assets
$596K
Other assets
$148K
Less accumulated
depreciation and...
$4,828K
Total assets
$93,003K
Total liabilities and
stockholders equity
$93,003K
Total stockholders'
equity
$67,288K
Total current
liabilities
$15,148K
Long-term operating lease
liability, net of current...
$10,308K
Long-term financing lease
liability, net of current...
$259K
Noncontrolling interest in
pangu biopharma...
-$192K
Total atyr pharma
stockholders equity
$67,480K
Accrued expenses
$9,791K
Accounts payable
$3,891K
Current portion of
operating lease liability
$836K
Current portion of
financing lease liability
$630K
Accumulated deficit
-$606,164K
Accumulated other
comprehensive loss
-$8K
Additional paid-in capital
$673,554K
Common stock, 0.001 par
value per share...
$98K
Back
Back
Balance Sheet
source: myfinsight.com
aTYR PHARMA INC (ATYR)
aTYR PHARMA INC (ATYR)